Childrens Robitussin Cough And Cold Cf Liquid
NDC Package 0031-8716-12
Package Information
Childrens Robitussin Cough And Cold Cf (dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride) liquids is measure only with dosing cup providedkeep dosing cup with productml = milliliterdo not take more than 6 doses in any 24-hour periodagedosechildren under 4 yearsdo not usechildren 4 to under 6 years5 ml every 4 hourschildren 6 to under 12 years10 ml every 4 hoursadults and children 12 years and over20 ml every 4 hours. This formulation utilizes a liquid delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0031-8716 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1370205 - dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution
- RxCUI: 1370205 - dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
- RxCUI: 1370205 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG per 10 ML Oral Solution
- RxCUI: 1370205 - dextromethorphan hydrobromide 5 MG / guaifenesin 50 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0031 - Haleon Us Holdings Llc
- 0031-8716 - Childrens Robitussin Cough And Cold Cf
- 0031-8716-12 - 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
- 0031-8716 - Childrens Robitussin Cough And Cold Cf
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0031-8716-12 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Childrens Robitussin Cough And Cold Cf, a human over the counter drug labeled by Haleon Us Holdings Llc. This liquid is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on September 01, 2009. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00031871612. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.